Latest papers

Intratumoral Wnt1 expression affects survivin gene expression in non-small cell lung cancer.

Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines.

Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) are potential targets in uterine leiomyosarcoma.

Lithium induces mortality in medulloblastoma cell lines.

Evaluation of cytotoxicity and radiation enhancement using 1.9 nm gold particles: potential application for cancer therapy.

Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells.

Cell-permeable peptide DEPDC1-ZNF224 interferes with transcriptional repression and oncogenicity in bladder cancer cells.

STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer.

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34.

Exon-level microarray analyses identify alternative splicing programs in breast cancer.

IL-22 defines a novel immune pathway of antifungal resistance.

Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.

Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.

Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.

Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.

Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.

Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.

Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.

Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.

Wnt inhibitor Dickkopf-1 as a target for passive cancer immunotherapy.